Aniracetam enhances cortical dopamine and serotonin release via cholinergic and glutamatergic mechanisms in SHRSP

Masatoshi Shirane; Kazuo Nakamura

doi:10.1016/s0006-8993(01)02939-0

journal article Oct 01, 2001

Aniracetam enhances cortical dopamine and serotonin release via cholinergic and glutamatergic mechanisms in SHRSP

Masatoshi Shirane Kazuo Nakamura

Brain Research Vol. 916 No. 1-2 pp. 211-221 · Elsevier BV

View at Publisher Save 10.1016/s0006-8993(01)02939-0

Topics

No keywords indexed for this article. Browse by subject →

References

48

[1]

Arborelius "The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons" Naunyn Schmiedeberg’s Arch. Pharmacol. (1993) 10.1007/bf00165384

[2]

Arborelius "(R)-8-OH-DPAT preferentially increases dopamine release in rat medial prefrontal cortex" Acta Physiol. Scand. (1993) 10.1111/j.1748-1716.1993.tb09584.x

[3]

Black "Effect of AMPA receptor modulators on hippocampal and cortical function" Eur. J. Pharmacol. (2000) 10.1016/s0014-2999(00)00120-5

[4]

Blaha "Modulation of dopamine efflux in the nucleus accumbens after cholinergic stimulation of the ventral tegmental area in intact, pedunculopontine tegmental nucleus-lesioned, and laterodorsal tegmental nucleus-lesioned rats" J. Neurosci. (1996) 10.1523/jneurosci.16-02-00714.1996

[5]

Doherty "Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area" Brain Res. (2000) 10.1016/s0006-8993(00)02062-x

[6]

Ferré "Dopamine D2 receptor-mediated regulation of serotonin extracellular concentration in the dorsal raphe nucleus of freely moving rats" J. Neurochem. (1993) 10.1111/j.1471-4159.1993.tb02187.x

[7]

Fu "Systemic nicotine stimulates dopamine release in nucleus accumbens: re-evaluation of the role of N-methyl-d-aspartate receptors in the ventral tegmental area" J. Pharmacol. Exp. Ther. (2000) 10.1016/s0022-3565(24)39093-7

[8]

Giovannini "Oxiracetam and aniracetam increase acetylcholine release from the rat hippocampus in vivo" Drug Dev. Res. (1993) 10.1002/ddr.430280409

[9]

Graeff "Role of 5-HT in stress, anxiety, and depression" Pharmacol. Biochem. Behav. (1996) 10.1016/0091-3057(95)02135-3

[10]

Guan "Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release" Brain Res. Bull. (1989) 10.1016/0361-9230(89)90198-6

[11]

Healy "Ionotropic glutamate receptor modulation preferentially affects NMDA receptor expression in rat hippocampus" Synapse (2000) 10.1002/1098-2396(20001201)38:3<294::aid-syn8>3.0.co;2-u

[12]

Kalivas "Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes" J. Pharmacol. Exp. Ther. (1989) 10.1016/s0022-3565(25)20732-7

[13]

LeDoux "Brain mechanisms of emotion and emotional learning" Curr. Opin. Neurobiol. (1992) 10.1016/0959-4388(92)90011-9

[14]

Le Moal "Mesocorticolimbic dopaminergic network: functional and regulatory roles" Physiol. Rev. (1991) 10.1152/physrev.1991.71.1.155

[15]

Maione "Metabotropic glutamate receptors modulate serotonin release in the rat periaqueductal gray matter" Naunyn Schmiedeberg’s Arch. Pharmacol. (1998) 10.1007/pl00005272

[16]

Martin "Pharmacology of aniracetam: a novel pyrrolidinone derivative with cognitive enhancing activity" Drug Invest. (1993) 10.1007/bf03258426

[17]

McDonough "A study of the N-methyl-d-aspartate antagonistic properties of anticholinergic drugs" Pharmacol. Biochem. Behav. (1995) 10.1016/0091-3057(94)00372-p

[18]

Minabe "The depletion of brain serotonin levels by para-chlorophenylalanine administration significantly alters the activity of midbrain dopamine cells in rats: an extracellular single cell recording study" Synapse (1996) 10.1002/(sici)1098-2396(199601)22:1<46::aid-syn5>3.0.co;2-i

[19]

Mesulam "Central cholinergic pathways in the rat: an overview based on alternative nomenclature (Ch1–Ch6)" Neuroscience (1983) 10.1016/0306-4522(83)90108-2

[20]

Mihailescu "Effects of nicotine and mecamylamine on rat dorsal raphe neurons" Eur. J. Pharmacol. (1998) 10.1016/s0014-2999(98)00658-x

[21]

Mylecharane "Ventral tegmental area 5-HT receptors: mesolimbic dopamine release and behavioural studies" Behav. Brain Res. (1996) 10.1016/0166-4328(96)00061-7

[22]

Nakamura "Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism" Eur. J. Pharmacol. (2001) 10.1016/s0014-2999(01)01005-6

[23]

Nakamura "Serotonergic mechanisms involved in the attentional and vigilance task performance of rats and the palliative action of aniracetam" Naunyn-Schmiedeberg’s Arch. Pharmacol. (2000) 10.1007/s002100000222

[24]

Nakamura "Impulsivity and AMPA receptors: aniracetam ameliorates impulsive behavior induced by a blockade of AMPA receptors in rats" Brain Res. (2000) 10.1016/s0006-8993(00)02160-0

[25]

Nakamura "Apomorphine-induced hypo-attention in rats and reversal of the choice performance impairment by aniracetam" Eur. J. Pharmacol. (1998) 10.1016/s0014-2999(97)01457-x

[26]

Nakamura "Scopolamine model of delirium in rats and reversal of the performance impairment by aniracetam" Drug Dev. Res. (1998) 10.1002/(sici)1098-2299(199802)43:2<85::aid-ddr1>3.0.co;2-l

[27]

Nakamura "Activation of the reticulothalamic cholinergic pathway by the major metabolites of aniracetam" Eur. J. Pharmacol. (1999) 10.1016/s0014-2999(99)00534-8

[28]

Nakamura "Site-specific activation of dopamine and serotonin transmission in the mesocorticolimbic pathway of rats by aniracetam" Brain Res. (2001) 10.1016/s0006-8993(01)02096-0

[29]

K. Nakamura, Y. Tanaka, Antidepressive effects of aniracetam and its mode of action in behavioral despair paradigm in rats, Psycopharmacology 29, September 2001.

[30]

Nisell "Condition-independent sensitization of locomotor stimulation and mesocortical dopamine release following chronic nicotine treatment in the rat" Synapse (1996) 10.1002/(sici)1098-2396(199604)22:4<369::aid-syn8>3.0.co;2-9

[31]

Nisell "Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area" Synapse (1994) 10.1002/syn.890160105

[32]

Ogiso "Pharmacokinetics of aniracetam and its metabolites in rat brain" Biol. Pharm. Bull. (2000) 10.1248/bpb.23.482

[33]

Ohishi "Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat" Neuroscience (1993) 10.1016/0306-4522(93)90485-x

[34]

Ohishi "Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study" J. Comp. Neurol. (1993) 10.1002/cne.903350209

[35]

Papke "Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes" J. Pharmacol. Exp. Ther. (2001) 10.1016/s0022-3565(24)29581-1

[36]

Paxinos (1986)

[37]

Pittaluga "Aniracetam, 1-BCP and cyclothiazide differentially modulate the function of NMDA and AMPA receptors mediating enhancement of noradrenaline release in rat hippocampal slices" Naunyn Schmiedeberg’s Arch. Pharmacol. (1999) 10.1007/pl00005352

[38]

Prisco "Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo" J. Pharmacol. Exp. Ther. (1994) 10.1016/s0022-3565(25)22843-9

[39]

Rayport "Glutamate is a cotransmitter in ventral midbrain dopamine neurons" Parkinsonism Relat. Disorders (2001) 10.1016/s1353-8020(00)00068-7

[40]

Reuben "Nicotinic receptors modulating somatodendritic and terminal dopamine release differ pharmacologically" Eur. J. Pharmacol. (2000) 10.1016/s0014-2999(00)00004-2

[41]

Ribeiro "Effects of systemic nicotine on serotonin release in rat brain" Brain Res. (1993) 10.1016/0006-8993(93)90121-3

[42]

Schilström "N-Methyl-d-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens" Neuroscience (1998) 10.1016/s0306-4522(97)00243-1

[43]

Shirane "Group II metabotropic glutamate receptors are a common target of N-anisoyl-GABA and 1S,3R-ACPD in enhancing ACh release in the prefrontal cortex of freely moving SHRSP" Neuropharmacology (2000) 10.1016/s0028-3908(99)00271-3

[44]

Sziraki "Receptor systems participating in nicotine-specific effects" Neurochem. Int. (1998) 10.1016/s0197-0186(98)00049-7

[45]

Tao "Differential effect of NMDA on extracellular serotonin in rat midbrain raphe and forebrain sites" J. Neurochem. (1996) 10.1046/j.1471-4159.1996.66031067.x

[46]

Tork "Anatomy of the serotonergic system" Ann. NY Acad. Sci. (1990) 10.1111/j.1749-6632.1990.tb16870.x

[47]

Toth "Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: role of glutamic acid" Neurochem. Res. (1992) 10.1007/bf00966669

[48]

Wonnacott "Presynaptic nicotinic ACh receptors" Trends Neurosci. (1997) 10.1016/s0166-2236(96)10073-4

Metrics

26

Citations

48

References

Details

Published: Oct 01, 2001
Vol/Issue: 916(1-2)
Pages: 211-221
License: View

Authors

Cite This Article

Masatoshi Shirane, Kazuo Nakamura (2001). Aniracetam enhances cortical dopamine and serotonin release via cholinergic and glutamatergic mechanisms in SHRSP. Brain Research, 916(1-2), 211-221. https://doi.org/10.1016/s0006-8993(01)02939-0

Aniracetam enhances cortical dopamine and serotonin release via cholinergic and glutamatergic mechanisms in SHRSP

You May Also Like